
Sue Siegel, MS
Sue Siegel is CEO of GE Ventures, GE’s growth and innovation business comprised of new market development, equity investing, new business creation and licensing. Sue has more than 30 years
Every Friday, get the latest funding opportunities in your inbox. Sign up for the Friday Funding Opportunities newsletter.
Get the latest news, updates, funding opportunities and essential information for members of the Brigham research community
Are you a Brigham researcher? Check out our monthly forum for researchers to hear the latest updates, news and resources at Research Connection LIVE.
You can also find out about other virtual events, events open to the public, and internal research events for the Brigham community by viewing the calendar.
Discover Brigham showcases cutting-edge science from our investigators and innovators each year. This year, a new video series invites the public to learn about the impact of research, discovery and innovation at the Brigham.
Sue Siegel is CEO of GE Ventures, GE’s growth and innovation business comprised of new market development, equity investing, new business creation and licensing. Sue has more than 30 years
Dr. Leiden is the Executive Chairman of Vertex Pharmaceuticals. He received his B.A., M.D. and Ph.D. degrees with honors from the University of Chicago. He is a physician and scientist
Carol Greider, PhD is the Daniel Nathans Professor and Director of Molecular Biology and Genetics at Johns Hopkins University. Dr Greider is a molecular biologist who discovered the enzyme telomerase
Do you work at the Brigham? Having trouble with something and not sure who to ask?